WO2025233679 - COMPOSITIONS AND METHODS RELATED TO A COMBINATION THERAPY OF STING AGONISTS AND ANTIBODY DRUG CONJUGATES
National phase entry is expected:
Publication Number
WO/2025/233679
Publication Date
13.11.2025
International Application No.
PCT/IB2025/000242
International Filing Date
08.05.2025
Title **
[English]
COMPOSITIONS AND METHODS RELATED TO A COMBINATION THERAPY OF STING AGONISTS AND ANTIBODY DRUG CONJUGATES
[French]
COMPOSITIONS ET MÉTHODES ASSOCIÉES À UNE POLYTHÉRAPIE D'AGONISTES DE STING ET DE CONJUGUÉS ANTICORPS-MÉDICAMENT
Applicants **
LIGACHEM BIOSCIENCES INC.
CHANG, Sook, Kyung
OH, Jihye
PARK, Yun-Hee
HAN, Nara
SONG, Ho, Young
KIM, Sung, Min
CHUNG, Chul-Woong
Inventors
CHANG, Sook, Kyung
OH, Jihye
PARK, Yun-Hee
HAN, Nara
SONG, Ho, Young
KIM, Sung, Min
CHUNG, Chul-Woong
Priority Data
63/644,227
08.05.2024
US
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| Number of Office Actions | * |
| * | |
International Searching Authority |
MOIP
* |
| Recordal of a Change of the Applicant's Name/Address |
Change of Applicant's Name and Address
* |
| Type of Assignment |
The Standard Agent's Assignment
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Patent Delivery |
Send the Letters Patent by Courier
* |
| 译文 |
|
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing, Examination, Granting | 8630 | |
| EPO | Filing, Examination, Granting | 137740 | |
| Japan | Filing, Examination, Granting | 4926 | |
| South Korea | Filing, Examination, Granting | 6160 | |
| USA | Filing, Examination, Granting | 28840 |
Total:
186,296
Contact Us
Abstract[English]
The disclosure provides combination therapy methods of treating diseases (such as cancer) comprising a compound represented by formula (I), or a pharmaceutically acceptable salt thereof, and an antibody-drug conjugate.[French]
La divulgation concerne des méthodes de polythérapie pour le traitement de maladies (telles que le cancer) faisant intervenir un composé représenté par la formule (I), ou un sel pharmaceutiquement acceptable de celui-ci, et un conjugué anticorps-médicament.